Skip to main content

Table 3 Median CVI (%) of healthy and chronic diseases in the Ricos C. et al. study and mean CVI (%) of HIV-uninfected and infected men in our study

From: Long-term intra- and inter-individual biological variation of serum lipid of HIV-infected and uninfected men participating in the Los Angeles Multi-Center AIDS Cohort Study (MACS)

Median CVI (%) of Ricos C. et al. [28] HDL-C LDL-C T. Cholesterol Triglycerides
Healthy subjects 7.1 8.3 6.0 20.9
Chronic liver Disease - - 5.2 -
Chronic renal failure 9.5 - - 15.4
Coronary heart disease - 9.5 - -
Diabetes Mellites Type I 7.7 - 7.2 20.0
Diabetes Mellites Type II - - - -
Hypertension 8.7 - 7.0 21.8
Impaired renal function - - - -
Lipid disorders 7.1 7.8 5.0 17.8
Mild Hypercholesterolemia - 6.6 4.7 19.6
Our study
HIV-uninfected on CLDs
(1 year) 13.4 15.8 10.6 40.7
(17 year) 15.9 24.9 16.1 43.8
HIV-uninfected not on CLDs
(1 year) 14.1 15.8 10.2 33.6
(17 year) 13.8 15.8 11.0 36.6
HIV-infected on CLDs
(1 year) 16.0 21.4 13.6 60.4
(17 year) 19.5 27.3 18.6 69.0
HIV-infected not on CLDs (1 year)
(17 year) 16.7 16.2 10.0 40.0
19.6 20.8 13.4 47.0